Drug discrimination in human post-addicts: agonist/antagonist opioids.
Preston
K
K
Johns Hopkins University School of Medicine, Department of Psychiatry, Baltimore, Maryland.
Bigelow
G
G
Bickel
W
W
Liebson
I
I
D002047:Buprenorphine / Q000494:pharmacology; D002077:Butorphanol / Q000494:pharmacology; D004193:Discrimination Learning / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D004091:Hydromorphone / Q000494:pharmacology; D008297:Male; D009292:Narcotic Antagonists / Q000494:pharmacology*; D009294:Narcotics / Q000494:pharmacology*; D009293:Opioid-Related Disorders / Q000503:physiopathology*; D010423:Pentazocine / Q000494:pharmacology
D009292:Narcotic Antagonists; D009294:Narcotics; D002047:Buprenorphine; D004091:Hydromorphone; D002077:Butorphanol; D010423:Pentazocine